MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Old diabetes drug, new hope: metformin tested to stop blood cancer before it starts
Prevention OngoingThis study tests whether metformin, a widely used diabetes medication, can prevent multiple myeloma in people with two precursor conditions: MGUS and smoldering multiple myeloma. Sixty participants will receive either metformin or a placebo for up to three years. The goal is to s…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention
Last updated Jun 23, 2026 19:18 UTC
-
Plant-Based diet trial aims to stop precancerous blood condition from turning into multiple myeloma
Prevention OngoingThis study tests whether a plant-based diet is practical for overweight people with MGUS or smoldering multiple myeloma, two conditions that can lead to multiple myeloma. Researchers will measure weight loss and how well participants stick to the diet over 12 weeks. They will als…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 15, 2026 18:56 UTC
-
Iceland launches massive screening study for early cancer detection
Knowledge-focused OngoingThis study is screening over 80,000 people in Iceland to see if early detection of a condition called MGUS can prevent or improve outcomes for multiple myeloma, a type of blood cancer. Participants are randomly assigned to routine care or closer monitoring. The goal is to compare…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: University of Iceland • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:59 UTC
-
Massive MGUS screening aims to unlock early myeloma clues
Knowledge-focused ENROLLING_BY_INVITATIONThis study screens 1000 adults aged 40 and older for MGUS, a condition with an abnormal blood protein that can sometimes lead to multiple myeloma. Researchers want to learn about genetic and immune factors behind MGUS, especially in diverse populations. The goal is to improve ear…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:54 UTC